Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Recruiting · NCT07257484 · Registry updated 2026-07-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors | Body Weight, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, skin disorder | Recruiting | Phase 4 | 2026-07-22 | NCT07257484 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Center for Advancing Translational Sciences (NCATS) | 127 |
| Weill Medical College of Cornell University | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Weill Cornell Medicine | New York | United States | 66 |